KP
Kairos Pharma, Ltd.
🇺🇸XNYS.KAPAUnited StatesHealthcare
$1.78USDdown -0.06 (-3.26%)OpenEnd of day6:13 PM
Price$1.78-0.06 (-3.26%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- New York Stock Exchange . XNYS
- Type
- Stock
- ISIN
- US48301N1046
- CUSIP
- 48301N104
Company
- Employees
- 1
- Headquarters
- Los Angeles, United States
- Website
- https://kairospharma.com
- CEO
- Dr. John S. Yu M.D., Ph.D.
Market
- Shares outstanding
- 21.4M
- Market cap
- $38.11M
Highlights
- Market cap
- $38.11M
- EPS LTM
- -$0.28
- P/E LTM
- -2.02
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$5.84M-64.85%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$3.76M+20.02%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.